|
eczema-psoriasis
 9/9/2010 Starting From Scratch: Career Counseling To Young Patients Or Adolescents At Risk For Neurodermatitis
A child who can't stop scratching himself may well be suffering from atopic dermatitis, also known as neurodermatitis. Extreme irritability of the skin with a concomitant urge to scratch is typical of the disorder. The condition often appears during the first year of life and is on the increase in industrialized countries...
9/9/2010 NICE Improves Access To Drug Treatments For Psoriatic Arthritis
The National Institute for Health and Clinical Excellence (NICE) has extended the range of drugs that NHS healthcare professionals can prescribe for people who have active and progressive psoriatic arthritis...
9/9/2010 UV-B Treatment May Improve Psoriasis And Vitamin D Levels
Treatment with narrow-band UV-B rays may increase serum levels of vitamin D in the wintertime while clearing psoriasis, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis affects 1.5 percent to 3 percent of the population, according to background information in the article...
9/9/2010 Skin Condition Associated With Depression, Anxiety And Suicidal Feelings
Individuals with psoriasis appear to have an increased risk of depression, anxiety and suicidality, according to a report in the August issue of Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis affects 1 percent to 3 percent of the general population, and estimates suggest 0.4 percent to 2.3 percent of adults have the condition but have not been diagnosed...
9/9/2010 Mickelson Announcement Prompts Expedited Filing Of Psoriasis Research Plan With FDA By Energex Systems, Inc.
A research plan that is designed to determine the degree of effectiveness of an experimental non-drug therapy known as ImmunoModulation for the treatment of psoriasis as a primary indication and psoriatic arthritis as a secondary indication, will be filed with the Federal Food and Drug Administration in an expedited manner...
9/9/2010 Women Who Drink Beer Regularly More Likely To Develop Psoriasis
Women who drink beer regularly seem to have a higher risk of developing psoriasis, according to a study published in Archives of Dermatology, a JAMA/Archives journal. The link does not apply to light beer or wines or spirits (liquor), the researchers say. The authors write: Psoriasis is a common immune-mediated skin disease...
9/9/2010 Psoriasis Linked To Higher Depression, Anxiety And Suicidal Feelings Risk
Patients with psoriasis have a higher risk of developing depression or anxiety, and having suicidal feelings, says a report published today in Archives of Dermatology, a JAMA/Archives (Journal of the American Medical Association) journal. Psoriasis is a dry, scaly skin disorder...
9/9/2010 Paracetamol (Acetaminophen, Tylenol) Doubles Risk Of Asthma And Eczema In Adolescents
Acetaminophen, more commonly known as Tylenol in the USA and paracetamol in Europe has been linked to the development of asthma and eczema among adolescents. A new study reveals that even monthly use of acetaminophen can more than double the risk, while yearly use may increase the risk by 50%...
9/9/2010 Obesity In Early Adulthood Associated With Increased Risk Of Psoriatic Arthritis
Among persons with psoriasis, those who reported being obese at age 18 had an increased risk of developing psoriatic arthritis, according to a report in the July 19 issue of Archives of Dermatology, one of the JAMA/Archives journals. Psoriatic arthritis is a specific type of arthritis that develops in the joints of some patients who have psoriasis...
9/9/2010 Cellceutix Corporation Selects Destum Partners To Partner Psoriasis Compound
Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its psoriasis compound, KM-133. Cellceutix management has carefully evaluated which direction to take in the development of KM-133 and has concluded that this is the best way to create shareholder value...
9/9/2010 Study Of Infections Associated With Eczema
The National Institute of Allergy and Infections Disease has awarded a five-year $31 million contract to National Jewish Health, which is leading a consortium of academic medical centers seeking to better understand skin infections associated with atopic dermatitis...
9/9/2010 PsoriasisDX Genetic Test For Psoriatic Arthritis Now Available In Europe As A CE Marked In Vitro Diagnostic Medical Device
Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive. CE Marking is required for certain product groups to indicate conformity with the essential requirements set out in European Directives...
9/9/2010 Decrease In Pediatric Eczema Following Probiotic Use During Pregnancy And Breast Feeding
Mothers who drank milk with a probiotic supplement during and after pregnancy were able to cut the incidence of eczema in their children by almost half, a new study published in the British Journal of Dermatology has shown...
9/9/2010 NICE Final Draft Guidance Recommends Improved Access To Psoriatic Arthritis Treatments
Three treatments for psoriatic arthritis are recommended in final draft guidance published by the National Institute of Health and Clinical Excellence (NICE). Etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) are proposed for treating adults with active and progressive psoriatic arthritis when specified criteria are met...
9/9/2010 Enbrel® (etanercept) Recommended In UK For Adults With Active And Progressive Psoriatic Arthritis By NICE
NICE (The National Institute for Health and Clinical Excellence) has recommended Enbrel® (etanercept) as a treatment option for adults with active and progressive psoriatic arthritis. NICE makes recommendations to the NHS (National Health Service) on new and existing medicines, treatments and procedures, and treating and caring for people with specific diseases and conditions...
9/9/2010 Comment On Research Suggesting Early Introduction Of Fish Decreases The Risk Of Eczema In Infants
'There is now a wealth of research indicating that a person's diet can contribute to their risk of developing asthma and allergies, most likely as a result of their antioxidant, lipid and vitamin E intake...
9/9/2010 Comment On Research Linking Twins' Birthweight And Risk Of Asthma And Eczema
'There is now a broad spectrum of evidence which suggests that the pre-natal environment, including factors such as family history and the mother's diet during pregnancy, can influence whether or not a child will go on to develop asthma or allergy symptoms...
9/9/2010 PhotoMedex Announces Clinical Trial Using The XTRAC Velocity(R) Laser In The Treatment Of Severe Generalized Psoriasis
PhotoMedex, Inc. (Nasdaq: PHMD) announced that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatment of generalized psoriasis when used in combination with Clobex® spray. Dr...
9/9/2010 Can-Fite BioPharma Announces Opening Of CF101 Dermatology IND With Phase 2/3 Psoriasis Protocol
Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite...
9/9/2010 What Causes Dandruff? How Can I Treat Dandruff?
The exact cause of dandruff, also known as scurf or Pityriasis simplex capillitii is unknown. However, most experts do agree that it is not caused by poor hygiene. Not enough hair brushing - People who do not comb/brush their hair regularly have a slightly higher risk of having dandruff - this is because they are not aiding the shedding of skin that combing/brushing provides...
9/9/2010 When Helper Cells Aren't Helpful
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells...
9/9/2010 Retinoid Use Not Associated With Fracture Risk
Individuals treated for acne, psoriasis or another skin condition with vitamin A analogues (retinoids) do not appear to be at increased risk of fracture, according to a report in the May issue of Archives of Dermatology, one of the JAMA/Archives journals...
9/9/2010 STELARA™ Significantly Improves Symptoms Of Depression, Anxiety And Health-Related Quality Of Life In Patients With Moderate To Severe Psoriasis
New research published online in the Journal of the American Academy of Dermatology (JAAD) shows that treatment with STELARA(TM)(Black Triangle Drug) (ustekinumab) significantly improves symptoms of depression, anxiety and health-related quality of life in patients with moderate to severe psoriasis compared to placebo...
9/9/2010 Hopeless Parents Find Relief For Their Children's Eczema With Vidazorb(R) Belly Boost™
May is National Asthma and Allergy Awareness Month and, though many parents deal with their kids' allergies year-round, it's a time for education on the subject. One allergic reaction to food, fabric, grass, pollen, environmental factors, etc. is eczema, which recent statistics show develops in one out of ten children before the age of five...
9/9/2010 VBL Therapeutics Announces Positive Preclinical Data For VB-201 Against Psoriasis - First In New Class Of Orally Available Anti-Inflammatory Compounds
VBL Therapeutics today announced positive preclinical results evaluating VB-201 for the treatment of psoriasis. VB-201 is a first-in-class, orally administered immune response modifier expected to reduce inflammation by targeting key pro-inflammatory cytokines...
|
CanMedGlobal.com advantages
Save 50 to 90% off your local pharmacy
No Membership Fees
We Ship Internationally
Fast Service, Fast delivery time
|
|
|
|
|
